-transparent.png){kind=logo}
1. This study was designed to examine the effects of acipimox 250 mg three times daily and cholestyramine 4 g three times daily on plasma lipids and lipoproteins in 28 hypercholesterolaemic individuals in a prospective double-blind placebo controlled parallel group fashion. 2. Combined treatment with the two agents produced a mean reduction of 27% in plasma total cholesterol and a 32% fall in LDL cholesterol. Plasma triglyceride was reduced by 13% due to a 38% decrement in VLDL cholesterol. 3. In comparison treatment with cholestyramine alone resulted in a 12% fall in plasma cholesterol and a 15% fall in LDL cholesterol. In this group triglycerides and VLDL showed no significant change. 4. Studies of HDL subfraction mass showed that the addition of acipimox to resin therapy produced a mean increment of 45% in HDL2. 5. These results demonstrate the effectiveness of such a well tolerated low dosage combination therapy.
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1989,
Current medical research and opinion,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
May 1990,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1994,
International journal of clinical pharmacology research,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
December 1982,
Schweizerische medizinische Wochenschrift,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1981,
Atherosclerosis,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1973,
The Netherlands journal of medicine,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1992,
Diabetic medicine : a journal of the British Diabetic Association,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
January 1986,
European journal of clinical pharmacology,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
July 1991,
Drug and therapeutics bulletin,
J J Series, and
A Gaw, and
C Kilday, and
D K Bedford, and
A R Lorimer, and
C J Packard, and
J Shepherd
April 1992,
British journal of clinical pharmacology,
